1.TNF-alpha upregulate MUC5AC mucin secretion through COX2/PGE2 mechanism.
Chinese Journal of Applied Physiology 2008;24(1):120-I
Cell Line
;
Cyclooxygenase 2
;
metabolism
;
Dinoprostone
;
genetics
;
metabolism
;
Epithelial Cells
;
drug effects
;
metabolism
;
Humans
;
Mucin 5AC
;
genetics
;
secretion
;
RNA, Messenger
;
genetics
;
secretion
;
Respiratory System
;
cytology
;
Tumor Necrosis Factor-alpha
;
pharmacology
;
Up-Regulation
;
drug effects
2.Clinical observation of sitagliptin combined with insulin aspart 30 with in the treatment of secondary failure of sulphonylurea in type 2 diabetes mellitus
Chinese Journal of Postgraduates of Medicine 2016;39(3):258-260
Objective To observe the effect of sitagliptin combined with insulin aspart 30 in the treatment of secondary failure of sulphonylurea in type 2 diabetes mellitus. Methods Fifty-six cases were divided into group A and group B in random block design, with 28 cases of each group. The patients in group A was treated with sitagliptin combined with insulin aspart 30, while the patients in group B was given subcutaneous injection of insulin aspart 30R. All patients were treated for 12 weeks. Fasting plasma glucose(FPG), 2-hour postprandial plasma glucose(2 hPG), glycosylated hemeglobin(HbA1c), insulin secretion index (HOMA-β), body mass index (BMI), and incidence of low blood glucose before and after treatment were compared. Results Compared with that in group B, FPG [(5.61 ± 1.14) mmol/L vs. (7.8 ± 1.22) mmol/L], 2 hPG [(7.62 ± 1.35) mmol/L vs(9.72 ± 1.41) mmol/L] and HbA1c [(7.11 ± 0.83)%vs.(8.32 ± 1.04)%] in group A had a significant decrease;HOMA-β[(50.31 ± 5.12) vs. (41.86 ± 4.53)] of group A was higher than that of group B (P
5.Effect of Different Does of Simvastatin in Reducing Serum Lipid
Zhe QI ; Jilin CHEN ; Li FANG ; Julan XIANG ; Min WANG
Herald of Medicine 2001;(3):152-153
Objective:Comparing the effect of different doses of simvastatin in lowering the serum lipid.Methods:79 patients were randomized into group A and group B,and were given simvastatin 10 mg*d-1 (group A) and 20 mg*d-1 (group B),respectively for a total of 8 weeks.Results:Comparing with baseline,in group A,TC,TG,LDL-C were decreased by 23.4%,20.0% and 30.7%,respectively (P<0.01); HDL-C was increased by 17.5%.The content of serum TC,TG and LDL-C was decreased to the normal range in 12.8%,28.2% and 15.4% of the patients in group A.For the group B,TC,TG,LDL-C were decreased by 32.7%,22.8% and 42.8%,respectively (P<0.01); HDL-C was increased by 13.7%.The content of serum TC,TG and LDL-C was decreased to the normal range in 65.0%,57.5% and 65.0% of the group B patients.Conclusion:Oral intake of 20 mg of simvastatin once a day can effectively reduce the serum lipid.The patients can well tolerate and no obvious side effect was observed in our study.
7.A cross-sectional study on the use of parenteral nutrition presciptions in patients with cancer in a tertia-ry hospital
Qi XIANG ; Zhigang LI ; Shuo DING ; Yan CHANG ; Yanru SHI
Chinese Journal of Clinical Nutrition 2017;25(2):99-103
Objective To investigate the application of the parenteral nutrition prescriptions for tumor patients in a tertiary hospital .Methods In this cross-sectional study , the parenteral nutrition prescriptions of all tumor inpatients in a tertiary hospital were collected from May to June in 2015 .The general data of patients who had used parenteral nutrition , the types of parenteral nutrition products , as well as the ratio of energy to ni-rogen ( E/N) , glucose/lipid ( G/L) ratio, non-protein energy to nitrogen ratio , and liquid volume were recor-ded and analyzed .Results Parenteral nutrition prescriptions were collected from 528 patients and showed high irrationality.The nutrient insufficiency rate was nearly 58.3%.The E/N (100:1 ~200:1) accounted for 32.3%and the G/L ( 1:1 ~2:1 ) 20.6%.Conclusions The rational application of parenteral nutrition should be a priority in clinical settings .A clinical nutrition supporting team may be established in tertiary hospi-tals to guide the appropriate use of parenteral nutrition .
8.Effect of Probiotics on Feeding Intolerance in Infants with Very Low Birth Weight
xiang-ying, HE ; qi, LI ; kun, LIANG ; qun-wen, XIAO
Journal of Applied Clinical Pediatrics 1986;0(02):-
Objective To explore effect of probiotics on improving the feeding intolerance in very low birth weight infants(VLBWI). Methods Sixty cases of VLBWI were randomly divided into two groups, 30 infants as therapy group,another 30 infants as control group.All infants in two groups were given aggressive intravenous nutrition and enteral feeding with preterm formulars. At the same time, probiotics were administered combined with preterm formulars to infants in therapy group. Milk amount, gastric residual, initial time of enteral feeding, time required for full enteral feeding and body weight on day 21 after birth were all recorded.Results Rate of no gastric residual increased significantly in therapy group compared with that of control group(t=6.24 P